In vivo immune responses to Candida albicans modified by treatment with recombinant murine gamma interferon.

The immunologic effects of in vivo administration of recombinant murine gamma interferon (rMuIFN-gamma) were determined in a murine model of candidiasis. Naive mice were given graded doses of rMuIFN-gamma and then challenged intravenously with Candida albicans. Increased morbidity and mortality were...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Infect Immun
Principais autores:	Garner, R. E., Kuruganti, U., Czarniecki, C. W., Chiu, H. H., Domer, J. E.
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1989
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC313359/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2498208/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/iai.57.6.1800-1808.1989
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!